Furthermore, it has been reported in observational studies that Fetuin-A circulating levels are increased in MASLD patients, and elevated serum Fetuin-A is an independent predictor of MASLD occurrence [68]. The gene discussed is AHSG; the disease is metabolic dysfunction-associated steatotic liver disease.